Index DJIA, S&P 500
P/E 18.33
EPS (ttm) 9.00
Insider Own 0.14%
Shs Outstand 2.41B
Perf Week 5.49%
Market Cap 396.65B
Forward P/E 14.80
EPS next Y 11.14
Insider Trans -0.60%
Shs Float 2.40B
Perf Month 4.94%
Enterprise Value 410.13B
PEG 3.07
EPS next Q 2.70
Inst Own 73.56%
Short Float 0.66%
Perf Quarter 6.80%
Income 21.81B
P/S 4.44
EPS this Y 6.60%
Inst Trans 1.15%
Short Ratio 2.00
Perf Half Y 14.11%
Sales 89.33B
P/B 5.08
EPS next Y 4.72%
ROA 11.93%
Short Interest 15.82M
Perf YTD 13.99%
Book/sh 32.47
P/C 10.23
EPS next 5Y 5.97%
ROE 29.45%
52W High 169.99 -3.02%
Perf Year 9.99%
Cash/sh 16.12
P/FCF 19.47
EPS past 3/5Y -9.49% 0.55%
ROIC 18.73%
52W Low 140.68 17.18%
Perf 3Y -7.57%
Dividend Est. 5.15 (3.13%)
EV/EBITDA 14.35
Sales past 3/5Y -1.79% 1.58%
Gross Margin 68.24%
Volatility 1.47% 1.41%
Perf 5Y 15.70%
Dividend TTM 5.02 (3.05%)
EV/Sales 4.59
EPS Y/Y TTM 29.21%
Oper. Margin 23.83%
ATR (14) 2.87
Perf 10Y 68.62%
Dividend Ex-Date May 27, 2025
Quick Ratio 1.03
Sales Y/Y TTM -0.37%
Profit Margin 24.41%
RSI (14) 72.45
Recom 2.20
Dividend Gr. 3/5Y 5.43% 5.54%
Current Ratio 1.26
EPS Q/Q 238.80%
SMA20 6.63%
Beta 0.39
Target Price 170.79
Payout 84.80%
Debt/Eq 0.67
Sales Q/Q 2.39%
SMA50 6.97%
Rel Volume 2.66
Prev Close 155.17
Employees 138100
LT Debt/Eq 0.49
Earnings Jul 16 BMO
SMA200 6.20%
Avg Volume 7.91M
Price 164.86
IPO Sep 25, 1944
Option/Short Yes / Yes
EPS/Sales Surpr. 3.29% 3.89%
Trades
Volume 15,282,762
Change 6.24%
Date
Action
Analyst
Rating Change
Price Target Change
May-13-25 Downgrade
Leerink Partners
Outperform → Market Perform
$153
Dec-10-24 Resumed
BofA Securities
Neutral
$166
Nov-15-24 Initiated
Wolfe Research
Outperform
$190
Jul-23-24 Downgrade
Daiwa Securities
Outperform → Neutral
$160 → $150
May-30-24 Resumed
Goldman
Neutral
$160
Apr-18-24 Upgrade
HSBC Securities
Hold → Buy
$170
Dec-13-23 Downgrade
Wells Fargo
Overweight → Equal Weight
$170 → $163
Dec-01-23 Upgrade
UBS
Neutral → Buy
$167 → $180
Oct-05-23 Initiated
RBC Capital Mkts
Outperform
$178
Sep-06-23 Initiated
HSBC Securities
Hold
$175
May-30-23 Resumed
Citigroup
Buy
$185
Mar-29-23 Initiated
UBS
Neutral
$164
Mar-01-23 Initiated
Guggenheim
Neutral
$161
Nov-18-22 Initiated
Credit Suisse
Neutral
$170
Oct-18-22 Initiated
Barclays
Equal Weight
$175
Oct-14-22 Reiterated
BofA Securities
Neutral
$185 → $178
Jun-22-22 Initiated
Daiwa Securities
Outperform
May-23-22 Resumed
SVB Leerink
Outperform
$200
Apr-06-22 Resumed
Morgan Stanley
Equal-Weight
$173
Mar-16-22 Downgrade
Bernstein
Outperform → Mkt Perform
$180 → $183
Show Previous Ratings
Today 02:18PM
12:58PM
12:57PM
(Investor's Business Daily)
12:55PM
12:45PM
12:31PM
Loading…
12:31PM
12:04PM
11:40AM
11:27AM
11:20AM
11:03AM
10:53AM
10:41AM
10:20AM
10:15AM
(Investor's Business Daily)
09:53AM
Loading…
09:53AM
(The Wall Street Journal)
09:53AM
(The Wall Street Journal)
09:52AM
(The Wall Street Journal)
09:30AM
09:27AM
09:19AM
(The Wall Street Journal)
08:47AM
(Investor's Business Daily)
08:42AM
(Investor's Business Daily)
08:41AM
08:41AM
08:22AM
08:18AM
08:01AM
(Investor's Business Daily)
07:45AM
07:43AM
07:26AM
Loading…
07:26AM
07:15AM
07:12AM
06:35AM
06:29AM
06:28AM
06:27AM
(Associated Press Finance)
06:27AM
(The Wall Street Journal)
06:26AM
06:25AM
06:20AM
06:20AM
05:30AM
05:18AM
04:27AM
(The Wall Street Journal)
03:43AM
(The Wall Street Journal)
12:09AM
Jul-15-25 07:00PM
06:50PM
06:50PM
06:50PM
05:52PM
(The Wall Street Journal)
04:55PM
09:10AM
06:30AM
05:08AM
04:17AM
(The Wall Street Journal)
03:00AM
Jul-14-25 05:09PM
04:58PM
04:58PM
04:45PM
(The Wall Street Journal)
04:24PM
(Investor's Business Daily)
11:50AM
11:03AM
10:24AM
(Investor's Business Daily)
10:08AM
09:34AM
09:32AM
09:17AM
08:20AM
(The Wall Street Journal)
07:56AM
(Associated Press Finance)
07:22AM
07:00AM
06:57AM
04:17AM
Jul-13-25 05:00PM
03:19PM
(Investor's Business Daily)
02:00PM
10:00AM
07:51AM
05:12AM
05:00AM
Jul-12-25 02:32PM
09:36AM
Jul-11-25 06:00PM
04:56PM
11:10AM
10:34AM
10:10AM
09:15AM
08:31AM
08:00AM
07:48AM
04:05AM
04:01AM
03:55AM
03:10AM
Jul-10-25 11:40AM
09:34AM
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
REED JOHN C EVP, Innovative Medicine, R&D May 01 '25 Option Exercise 0.00 25,255 0 40,797 May 05 05:10 PM Decker Robert J VP Corporate Controller Feb 25 '25 Option Exercise 101.87 6,999 712,988 28,000 Feb 26 06:42 PM Decker Robert J VP Corporate Controller Feb 25 '25 Sale 165.88 6,999 1,160,994 21,001 Feb 26 06:42 PM Decker Robert J Officer Feb 25 '25 Proposed Sale 165.88 6,999 1,161,010 Feb 25 03:05 PM Schmid Timothy EVP, WW Chair, MedTech Feb 14 '25 Option Exercise 0.00 2,806 0 17,904 Feb 18 09:46 PM Schmid Timothy EVP, WW Chair, MedTech Feb 15 '25 Option Exercise 0.00 1,029 0 15,501 Feb 18 09:33 PM Schmid Timothy EVP, WW Chair, MedTech Feb 14 '25 Option Exercise 0.00 1,765 0 15,111 Feb 18 09:33 PM Schmid Timothy EVP, WW Chair, MedTech Feb 13 '25 Option Exercise 0.00 499 0 13,539 Feb 18 09:33 PM Schmid Timothy EVP, WW Chair, MedTech Feb 18 '25 Sale 156.15 403 62,928 15,098 Feb 18 09:33 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 15 '25 Option Exercise 0.00 607 0 91,037 Feb 18 09:16 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 14 '25 Option Exercise 0.00 7,367 0 96,674 Feb 18 09:16 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 13 '25 Option Exercise 0.00 651 0 89,603 Feb 18 09:16 PM Wolk Joseph J Exec VP, CFO Feb 15 '25 Option Exercise 0.00 1,971 0 6,113 Feb 18 09:13 PM Wolk Joseph J Exec VP, CFO Feb 14 '25 Option Exercise 0.00 19,330 0 20,661 Feb 18 09:13 PM Wolk Joseph J Exec VP, CFO Feb 13 '25 Option Exercise 0.00 1,779 0 1,779 Feb 18 09:13 PM REED JOHN C EVP, Innovative Medicine, R&D Feb 15 '25 Option Exercise 0.00 1,350 0 15,927 Feb 18 09:11 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 15 '25 Option Exercise 0.00 1,594 0 171,110 Feb 18 09:08 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 14 '25 Option Exercise 0.00 19,518 0 185,924 Feb 18 09:08 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 13 '25 Option Exercise 0.00 1,302 0 167,221 Feb 18 09:08 PM Swanson James D. EVP, CIO Feb 15 '25 Option Exercise 0.00 492 0 16,762 Feb 18 09:06 PM Swanson James D. EVP, CIO Feb 14 '25 Option Exercise 0.00 5,079 0 19,739 Feb 18 09:06 PM Swanson James D. EVP, CIO Feb 13 '25 Option Exercise 0.00 447 0 15,019 Feb 18 09:06 PM Mulholland Kristen EVP, Chief HR Officer Feb 15 '25 Option Exercise 0.00 419 0 13,095 Feb 18 09:05 PM Mulholland Kristen EVP, Chief HR Officer Feb 14 '25 Option Exercise 0.00 2,608 0 14,576 Feb 18 09:05 PM Mulholland Kristen EVP, Chief HR Officer Feb 13 '25 Option Exercise 0.00 411 0 12,100 Feb 18 09:05 PM Forminard Elizabeth Executive VP, General Counsel Feb 15 '25 Option Exercise 0.00 961 0 10,321 Feb 18 09:03 PM Forminard Elizabeth Executive VP, General Counsel Feb 14 '25 Option Exercise 0.00 2,203 0 11,366 Feb 18 09:03 PM Forminard Elizabeth Executive VP, General Counsel Feb 13 '25 Option Exercise 0.00 651 0 8,991 Feb 18 09:03 PM Duato Joaquin CEO and Chairman of the Board Feb 15 '25 Option Exercise 0.00 3,682 0 397,525 Feb 18 09:02 PM Duato Joaquin CEO and Chairman of the Board Feb 14 '25 Option Exercise 0.00 24,335 0 415,205 Feb 18 09:02 PM Duato Joaquin CEO and Chairman of the Board Feb 13 '25 Option Exercise 0.00 3,470 0 392,498 Feb 18 09:02 PM Decker Robert J VP Corporate Controller Feb 15 '25 Option Exercise 0.00 339 0 20,116 Feb 18 09:01 PM Decker Robert J VP Corporate Controller Feb 14 '25 Option Exercise 0.00 2,201 0 21,373 Feb 18 09:01 PM Decker Robert J VP Corporate Controller Feb 13 '25 Option Exercise 0.00 312 0 19,285 Feb 18 09:01 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 15 '25 Option Exercise 0.00 492 0 21,839 Feb 18 08:58 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 14 '25 Option Exercise 0.00 4,740 0 24,591 Feb 18 08:58 PM Broadhurst Vanessa EVP, Global Corp Affairs Feb 13 '25 Option Exercise 0.00 408 0 20,242 Feb 18 08:58 PM Duato Joaquin CEO and Chairman of the Board Feb 07 '25 Option Exercise 100.06 126,369 12,644,482 489,671 Feb 11 07:43 PM Wengel Kathryn E EVP, Chief TO and Risk Officer Feb 07 '25 Option Exercise 100.06 32,762 3,278,166 115,028 Feb 11 07:42 PM Taubert Jennifer L EVP, WWC. Innovative Medicine Feb 07 '25 Option Exercise 100.06 58,504 5,853,910 213,355 Feb 11 07:41 PM Wolk Joseph J Exec VP, CFO Feb 07 '25 Option Exercise 100.06 13,015 1,302,281 13,015 Feb 11 07:40 PM Wolk Joseph J Exec VP, CFO Feb 07 '25 Sale 153.89 13,015 2,002,878 0 Feb 11 07:40 PM Wolk Joseph J Officer Feb 07 '25 Proposed Sale 153.89 13,015 2,002,924 Feb 07 01:27 PM WEINBERGER MARK A Director Dec 12 '24 Buy 147.22 1,000 147,220 1,000 Dec 12 05:27 PM Hait William Former Officer Dec 04 '24 Proposed Sale 149.90 25,742 3,858,598 Dec 04 01:25 PM Decker Robert J VP Corporate Controller Aug 30 '24 Option Exercise 100.06 5,635 563,838 24,608 Sep 03 04:48 PM Decker Robert J VP Corporate Controller Aug 30 '24 Sale 165.06 5,635 930,113 18,973 Sep 03 04:48 PM Decker Robert J Officer Aug 30 '24 Proposed Sale 165.06 5,635 930,113 Aug 30 03:51 PM